Not just another telehealth company shipping out a standard dose and hoping for the best, but a platform built around personalized dosing protocols, weekly provider check-ins, and a clinical model that actually has published research behind it
A spokesperson for Eli Lilly, which manufactures tirzepatide and is not named in the suit, told Fierce Healthcare: "There are no human studieslet alone clinical trialsinvolving any oral tirzepatide product, meaning anyone selling oral tirzepatide is making unproven claims and experimenting on unsuspecting Americans." The named plaintiff, Darby Day, alleges he bought a one-month supply of the pills through MEDVi, a GLP-1-focused telehealth platform that appears to work with OpenLoop but is not named in the suit, for $279.99
Cell culture studies have shown that Larazotide prevents the redistribution of tight junction proteins (ZO-1, occludin, claudins) that occurs during zonulin start
Gastrointestinal losses combined with reduced food and fluid intake can deplete sodium, potassium, magnesium, and chloride, affecting cardiac rhythm, muscle function, and cellular metabolism
Hunger becomes more manageable, cravings diminish, and meals feel more satisfying despite smaller portion sizes
